Bracebridge Capital, LLC Alvotech Transaction History
Bracebridge Capital, LLC
- $128 Million
- Q1 2025
A detailed history of Bracebridge Capital, LLC transactions in Alvotech stock. As of the latest transaction made, Bracebridge Capital, LLC holds 2,705,304 shares of ALVO stock, worth $26.7 Million. This represents 20.4% of its overall portfolio holdings.
Number of Shares
2,705,304
Previous 2,705,304
-0.0%
Holding current value
$26.7 Million
Previous $35.7 Million
26.74%
% of portfolio
20.4%
Previous 5.53%
Shares
5 transactions
Others Institutions Holding ALVO
# of Institutions
50Shares Held
15.8MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA4.19MShares$41.3 Million0.0% of portfolio
-
Howard Marks Oaktree Capital Management LP | Los Angeles, Ca1.87MShares$18.4 Million0.54% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.4MShares$13.8 Million0.0% of portfolio
-
Littlejohn & CO LLC1.32MShares$13 Million6.46% of portfolio
-
Point State Capital LP New York, NY1.17MShares$11.6 Million0.18% of portfolio
About Alvotech
- Ticker ALVO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 248,650,000
- Market Cap $2.45B
- Description
- Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders, as well as cancer. The company's lead program is AVT02, a high concentration formulation biosimilar to Humira to treat various inflammatory condi...